Neuropathology characterization for the Brain Atlas Project
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026Q00313
NAICS
621511 - Medical Laboratories
Classification Code
Q301
Additional Details
Documents2
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a competitive combined synopsis/solicitation for commercial services under solicitation number 75N98026Q00313. This procurement seeks neuropathology characterization services in support of the Brain Atlas Project, a research initiative led by the National Institute on Aging (NIA) and its Center for Alzheimer’s Disease and Related Dementias. The project aims to advance understanding of the cellular differences between healthy brains and those affected by Alzheimer’s disease, with the ultimate goal of developing a comprehensive human brain atlas that maps cell types based on gene activity. This atlas will serve as a critical resource for researchers investigating disease-affected brain regions, gene expression changes, and potential therapeutic targets.
The scope of work encompasses the provision of neuropathology analysis services, including sample processing, digital imaging, and data platform support. The selected contractor will be expected to deliver high-quality, technically acceptable results that comply with the requirements outlined in the Statement of Work (SOW). Key deliverables include processed samples, digital imaging data, and integration with data platforms, all designed to facilitate the prioritization of target genes, pathways, and future therapeutics for Alzheimer’s disease.
The procurement is classified under NAICS code 621511 (Medical Laboratories), with a small business size standard of $41.5 million. This requirement is set aside exclusively for small businesses, ensuring that only qualified small business entities are eligible to compete. The contract will be awarded as a firm fixed price purchase order, with the period of performance spanning from June 1, 2026, to May 30, 2027. The place of performance is NIH/NIA, 9000 Rockville Pike RM 170, Bethesda, Maryland, USA.
Offerors must demonstrate their capability to meet the technical requirements, including sample processing, digital imaging, and data platform integration. Evaluation factors include technical acceptability (pass/fail), schedule and turnaround time, compliance with deliverables, staffing and key personnel, facilities and equipment, and price (Lowest Price Technically Acceptable, LPTA). Additional considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.
All proposals must include unit and total pricing, shipping and handling costs, delivery timeframe, delivery terms, F.O.B. point, product or catalog numbers (if applicable), and a detailed product/service description. Offerors are required to submit their Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification, and must be actively registered in the System for Award Management (SAM).
The solicitation incorporates Federal Acquisition Regulation (FAR) provisions and clauses, including FAR 52.212-1 (Instructions to Offerors), FAR 52.212-2 (Evaluation), FAR 52.212-3 (Offeror Representations and Certifications), FAR 52.212-4 (Contract Terms and Conditions), and FAR 52.212-5 (Contract Terms and Conditions Required to Implement Statutes or Executive Orders). The Defense Priorities and Allocations System (DPAS) is not applicable to this procurement.
Interested parties must submit their responses electronically by May 28, 2026, at 5pm EST, referencing solicitation number 75N98026Q00313. Submissions should be sent to Elaine Estrella, Contract Specialist ([email protected]), and Brian Lind, Contract Officer ([email protected]). The notice remains active and can be accessed via SAM.gov at https://sam.gov/opp/f4d25d2565cd4413a575b2cef8f18777/view.
This opportunity is ideal for small businesses with expertise in medical laboratory services, neuropathology analysis, and digital imaging/data platform integration. The contract requirements, evaluation criteria, and deliverables are expected to remain consistent throughout the contract lifecycle, providing a stable framework for performance and compliance.